Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricard Ferrer

Showing results (251-260 of 319) with videos related to

Pageof 32
Sort By:
Intensive Care Medicine|March 4, 2024
Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Frontiers in Medicine|August 1, 2022
One Year Overview and Follow-Up in a Post-COVID Consultation of Critically Ill PatientsJessica González, María Zuil, Iván D Benítez, et al.
Viruses|April 27, 2024
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE TrialsCharlotte Hedskog, Christoph D Spinner, Ulrike Protzer, et al.
The Lancet. Respiratory Medicine|May 23, 2025
Sepsis in patients who are immunocompromised: diagnostic challenges and future therapiesStefanie Deinhardt-Emmer, Benjamin G Chousterman, Joerg C Schefold, et al.
Intensive Care Medicine|January 3, 2024
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Journal of Anesthesia, Analgesia and Critical Care|February 24, 2026
The international, prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: results from the first 300 patientsRicard Ferrer, Matthias Thielmann, Moritz Unglaube, et al.
Intensive Care Medicine|January 22, 2025
Correction: Clinical features, etiologies, and outcomes in adult patients with meningoencephalitis requiring intensive care (EURECA): an international prospective multicenter cohort studyRomain Sonneville, Etienne de Montmollin, Damien Contou, et al.
Clinical and Translational Medicine|May 11, 2022
Proteomic profiling of lung diffusion impairment in the recovery stage of SARS-CoV-2-induced ARDSMaría C García-Hidalgo, Jessica González, Iván D Benítez, et al.
Critical Care (London, England)|February 9, 2022
Non-invasive oxygenation support in acutely hypoxemic COVID-19 patients admitted to the ICU: a multicenter observational retrospective studyPedro David Wendel-Garcia, Arantxa Mas, Cristina González-Isern, et al.
Emerging Microbes & Infections|May 23, 2022
Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDSMaría C García-Hidalgo, Jessica González, Iván D Benítez, et al.
Pageof 32

Showing results (251-260 of 319) with videos related to

Sort By:
Pageof 32
Intensive Care Medicine|March 4, 2024
Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Frontiers in Medicine|August 1, 2022
One Year Overview and Follow-Up in a Post-COVID Consultation of Critically Ill PatientsJessica González, María Zuil, Iván D Benítez, et al.
Viruses|April 27, 2024
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE TrialsCharlotte Hedskog, Christoph D Spinner, Ulrike Protzer, et al.
The Lancet. Respiratory Medicine|May 23, 2025
Sepsis in patients who are immunocompromised: diagnostic challenges and future therapiesStefanie Deinhardt-Emmer, Benjamin G Chousterman, Joerg C Schefold, et al.
Intensive Care Medicine|January 3, 2024
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Journal of Anesthesia, Analgesia and Critical Care|February 24, 2026
The international, prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: results from the first 300 patientsRicard Ferrer, Matthias Thielmann, Moritz Unglaube, et al.
Intensive Care Medicine|January 22, 2025
Correction: Clinical features, etiologies, and outcomes in adult patients with meningoencephalitis requiring intensive care (EURECA): an international prospective multicenter cohort studyRomain Sonneville, Etienne de Montmollin, Damien Contou, et al.
Clinical and Translational Medicine|May 11, 2022
Proteomic profiling of lung diffusion impairment in the recovery stage of SARS-CoV-2-induced ARDSMaría C García-Hidalgo, Jessica González, Iván D Benítez, et al.
Critical Care (London, England)|February 9, 2022
Non-invasive oxygenation support in acutely hypoxemic COVID-19 patients admitted to the ICU: a multicenter observational retrospective studyPedro David Wendel-Garcia, Arantxa Mas, Cristina González-Isern, et al.
Emerging Microbes & Infections|May 23, 2022
Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDSMaría C García-Hidalgo, Jessica González, Iván D Benítez, et al.
Pageof 32